(FPRX) |
| 0 (0%) 10-10 11:26 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 44.40 |
| Resistance 1: | 38.01 |
| Pivot price: | 37.87 |
| Support 1: | 37.74 |
| Support 2: | 37.57 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Fri, 16 Apr 2021
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics - PR Newswire
Thu, 04 Mar 2021
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash - PR Newswire
Wed, 25 Nov 2020
How a longtime Peninsula biotech company's stomach cancer drug moved closer to the finish line - The Business Journals
Thu, 12 Nov 2020
Five Prime Announces Pricing of Upsized Public Offering of Common Stock - Business Wire
Wed, 08 May 2019
Five Prime Therapeutics (FPRX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia
Wed, 18 Jun 2014
Five Prime To Present At Wells Fargo Conference; Webcast At 1:50 PM ET - RTTNews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
